Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

Post by geodcanon May 20, 2024 5:59pm
180 Views
Post# 36049124

Bux and Huang

Bux and Huangare holding the shareprice up with their hundreds of dollar investments.

It is their buying that is supporting this shareprice and not fundamentals, yet!

I am still on the bid for 200k shares and have been for a long time even though it doesn't get posted half the time.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities